FDA's Device Center Faces New Charge Of Whistleblower Retaliation
This article was originally published in The Gray Sheet
Executive Summary
Federal officials took steps last week to reinstate a recently fired reviewer in FDA's diagnostics office, claiming that agency actions may have violated the Whistleblower Protection Act.